Korea Advanced Institute of Science and Technology
6
2
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Increasing the Repertoire of Intermuscular Co-ordination Post Stroke Through EMG-Guided Human-Machine Interaction
Role: collaborator
Heart-Smile Training Intensive Introduction Program
Role: collaborator
Drug Response Testing and Repurposing Using Glioblastoma Organoid
Role: collaborator
Assessment of VZV-specific ELISPOT Assay for Predicting VZV Infection in Kidney Transplant Recipients (AVE-KT)
Role: collaborator
Cardiac Auscultation Using Smartphones
Role: collaborator
Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients
Role: collaborator
All 6 trials loaded